P1-185
外觀
| 臨床資料 | |
|---|---|
| 其他名稱 | (3E)-3-({[(2S)-2-Amino-3-methylbutanoyl]oxy}imino)pregn-4-en-20-one |
| 藥物類別 | 孕激素、神經甾體 |
| 識別資訊 | |
| |
| CAS號 | 1185297-01-1 |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| 化學資訊 | |
| 化學式 | C26H40N2O3 |
| 摩爾質量 | 428.62 g·mol−1 |
| 3D模型(JSmol) | |
| |
| |
P1-185(化學名:孕甾-4-烯-3,20-二酮 3-O-(L-纈氨酰)-E-肟,英語:pregn-4-ene-3,20-dione 3-O-(L-valine)-E-oxime)是一種含氮有機化合物,化學式C
26H
40N
2O
3,屬於人工合成的孕激素和神經甾體[1][2]。
參考文獻
[編輯]- ^ MacNevin CJ, Atif F, Sayeed I, Stein DG, Liotta DC. Development and screening of water-soluble analogues of progesterone and allopregnanolone in models of brain injury. J. Med. Chem. 2009, 52 (19): 6012–23. PMID 19791804. doi:10.1021/jm900712n.
- ^ Guthrie DB, Stein DG, Liotta DC, Lockwood MA, Sayeed I, Atif F, Arrendale RF, Reddy GP, Evers TJ, Marengo JR, Howard RB, Culver DG, Natchus MG. Water-soluble progesterone analogues are effective, injectable treatments in animal models of traumatic brain injury. ACS Med Chem Lett. 2012, 3 (5): 362–6. PMC 4025794
. PMID 24900479. doi:10.1021/ml200303r.